Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      • Home
      • Meghna A Singhania

      Articles By : Meghna A Singhania

      Based on Hospital data, NPPA fixed price of Calcium Carbonate tab, 4 other formulations

      Based on Hospital data, NPPA fixed price of Calcium Carbonate tab, 4 other formulations

      Meghna A Singhania10 March 2020 10:30 AM IST
      New Delhi: Based on Institutional Data received from Hospitals, the National Pharmaceutical Pricing Authority (NPPA) has fixed Ceiling Price of...
      Disposal of expired and unused medicines: Health Minister apprises parliament

      Disposal of expired and unused medicines: Health Minister apprises parliament

      Meghna A Singhania6 March 2020 11:21 AM IST
      New Delhi: Through a recent reply, the Minister of State for Health and Family Welfare (MOS Health) informed the Rajya Sabha about the rules for...
      Aurobindo Pharma gets official action indicated classification from USFDA for its plant

      Aurobindo Pharma gets official action indicated classification from USFDA for its plant

      Meghna A Singhania30 Jan 2020 4:14 PM IST
      New Delhi: Aurobindo Pharma has announced that the US Food and Drug Administration (FDA) classified the inspection of the company's oral solids...
      FICCI raises concern on delay by govt in notifying E-pharmacy rules

      FICCI raises concern on delay by govt in notifying E-pharmacy rules

      Meghna A Singhania17 Jan 2020 12:33 PM IST
      NEW DELHI: With the ongoing delay in the notification of e-Pharmacy draft rules, industry body FICCI has recently show concern pointing out that the...
      Healthcare sector adversely impacted due to NPPA regulatory measures: ICRA

      Healthcare sector adversely impacted due to NPPA regulatory measures: ICRA

      Meghna A Singhania15 Oct 2019 5:11 PM IST
      The sector’s performance had been adversely impacted in the past two years due to several regulatory measures, including the cap on prices of stents...
      CDSCO commitee warns against repacking of Active Pharmaceutical Ingredients into smaller packs by Wholesalers

      CDSCO commitee warns against repacking of Active Pharmaceutical Ingredients into smaller packs by Wholesalers

      Meghna A Singhania27 Sept 2019 12:19 PM IST
      New Delhi : Taking into consideration, the proposal on measures need to be taken to address the issue of repacking of Active Pharmaceutical...
      More than 10 percent of Drug samples from Government sources Not of Standard Quality

      More than 10 percent of Drug samples from Government sources Not of Standard Quality

      Meghna A Singhania25 Jun 2019 3:43 PM IST
      New Delhi: Estimated 10.02% medicines of the sample of medicines from government sources tested by the government were found to be Not of Standard...
      Refix ceiling price of Zydus Healthcare Tiotropium Inhalation: DoP directs NPPA

      Refix ceiling price of Zydus Healthcare Tiotropium Inhalation: DoP directs NPPA

      Meghna A Singhania23 Jun 2019 4:57 PM IST
      New Delhi: Allowing the review petition of Zydus Healthcare Limited regarding price fixation of Tiotropium Inhalation (MDI) 9 mcg/dose, the Department...
      Novo Nordisk gets USFDA for use of Victoza to treat type 2 diabetes in pediatric patients

      Novo Nordisk gets USFDA for use of Victoza to treat type 2 diabetes in pediatric patients

      Meghna A Singhania18 Jun 2019 4:07 PM IST
      US The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with...
      Ressurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licence

      Ressurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licence

      Meghna A Singhania29 May 2019 2:37 PM IST
      New Delhi: The billionaire entrepreneur, Dilip Shanghvi, founder of the 1983 established drug giant Sun Pharmaceuticals (Sun Pharma) is striving to...
      Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report

      Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report

      Meghna A Singhania26 May 2019 6:13 PM IST
      Shanghvi estimates that Sun Pharma has invested about $1 billion in its patented-drug programme so far. He says growth in the Indian generics...
      Sun Pharma submits proposal to CDSCO for manufacturing, marketing FDC to treat URTI; Details

      Sun Pharma submits proposal to CDSCO for manufacturing, marketing FDC to treat URTI; Details

      Meghna A Singhania25 May 2019 11:15 AM IST
      New Delhi: Dilip Shanghvi led Sun Pharma recently submitted a proposal to seek permission from the national regulatory authority, Central Drugs...
      Next

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok